Determination of Candidacy for Mechanical Circulatory Support: Importance of Clinical Indices

Journal of Heart and Lung Transplantation

Volumn 19, Issue 8, 2000, Pages

  Gronda, Edoardo ^a,c   Mangiavacchi, Maurizio ^a   Frigerio, Maria ^a   Oliva, Fabrizio ^a   Andreuzzi, Bruno ^a   Paolucci, Marco ^a   Masciocco, Gabriella ^a   Comerio, Gabriella ^a   Piccalò, Giacomo ^a   Moreo, Antonella ^a   Gabrielli, Domenico ^a   Barbieri, Pietro ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; CAPTOPRIL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FUROSEMIDE;

ASSISTED CIRCULATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; DEVICE; DISEASE COURSE; DISEASE SEVERITY; HEART TRANSPLANTATION; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW; SURVIVAL; TREATMENT OUTCOME;

EID: 4244194992     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1053-2498(00)00147-9     Document Type: Article

References (23)

1. Frigerio M, Gronda E, Mangiavacchi M, et al. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure. J Heart Lung Transplant 1997;16:160-8.
2. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation. A statement of health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation 1995;92:3593-12.
3. Frigerio M, Gronda E, Mangiavacchi M. Guida al trattamento intensivo dello scompenso refrattario. G Ital Cardiol 1994;24:1275-84.
4. Stevenson LW, Warner SL, Steine AE, et al. The impending crisis awaiting for heart transplantation modeling a solution based on selection. Circulation 1994;89:450-7.
5. Hill JD, Lemperle B, Levinson M, Poirer VL, Griffith BP. How much do we need to know before approving a ventricular assist device? Ann Thor Surg 1993;55:314-28.
6. Oz MC, Argenziano M. Bridge experience with long-term implantable left ventricular assist devices. Circulation 1997; 95:1844-52.
7. Hunt SA, Frazier OH. Mechanical circulatory support and cardiac transplantation. Circulation 1998;97:2079-90.
8. Stevenson LW, Couper G, Natterson B, et al. Target heart failure populations for newer therapies. Circulation 1995; 92(suppl II):II174-81.
9. Mancini D, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
10. Aguita M, Arizon J, Bueno G, et al. Clinical and hemodynamic predictors of survival in patients aged <65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1993;72:413-7.
11. Gronda E, Barbieri P, Frigerio M, et al. Prognostic indices in heart transplant candidates after first hospitalization triggered by the need of intravenous pharmacologic circulatory support. J Heart Lung Transplant 1999;18:654-63.
12. The CONSENSUS Trial Group. Effects of Enalapril on mortality in congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med 1987;316:1429-35.
13. Fonarow GC, Stevenson LW, Steimle, et al. Persistently high left ventricle filling pressures predict mortality despite angiotensin converting enzyme inhibition in advanced heart failure. Circulation 1994;90:I-488.
14. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation vs. angiotensin converting enzyme inhibition on mortality in advanced congestive heart failure. J Am Coll Cardiol 1992;19:842-50.
15. Lee TH, Hamilton MA, Stevenson LW, et al. Prognostic importance of sodium serum concentration and its modification by converting enzyme inhibition in patients with severe congestive heart failure. Circulation 1986;73:257-67.
16. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation vs angiotensin-converting enzyme inhibition on mortality in advanced heart failure: the Hy-C Trial. J Am Coll Cardiol 1992;19:842-50.
17. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-96.
18. Bristow MR. Tumor necrosis factor-α and cardiomyopathy. Circulation 1998;97:1340-41.
19. Stevenson LW. Tailored therapy before transplantation to effective treatment of advanced heart failure: effective use of vasodilators and diuretics. J Heart Lung Transplant 1991;10: 468-76.
20. Bourge RC, Naftel DC, Costanzo-Nordin MR, et al. Pretransplantation risk factors for deaths after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993;12:549-62.
21. Cohn JN, Johnson GR, Shabetai R, et al. Ejection fraction, peak oxygen consumption, cardiothoracic ratio, ventricular arrythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87(suppl. VI)VI6-16.
22. Good JM, Brady AJB, Noormohamed F, et al. Effect of intensive angiotensin II suppression on the diuretic response to furosemide during chronic ACE inhibition. Circulation 1994;90:220-24.
23. Motwani JG, Fenwick MK, Morton JJ, Struthers AD. Furosemide-induced natriuresis is augmented by ultra-low captopril but not by standard doses of captopril in chronic heart failure. Circulation 1992;86:439-45.